Enabling Clinical Trial Success

If you’re reading this, you may be considering participating in a clinical study. This is an exciting step in your health journey, but it’s crucial you ensure your rights, safety, and well-being are protected throughout the research process. Advocating for yourself and your health is vital to ensure you get the care you need and deserve.

In clinical research, finding the right participants for a study is like solving a puzzle. But the puzzle is more complex than just matching patients to trials—it involves earning their trust, understanding their needs, and helping them overcome barriers to participation. This is where advocacy partnerships come in.

Trust is the foundation of any meaningful relationship, especially when engaging patients in clinical studies. At its core, trust means having confidence in someone—believing they are genuine, sincere, and have your best interests at heart. It’s also about knowing that the information you receive is reliable and truly trustworthy. For patients living with rare diseases and serious conditions, trusting the people and process behind a clinical study can make all the difference.

This article emphasizes the benefits of incorporating pre-screening and phone screening into the clinical study recruitment process to overcome logistical challenges and improve participant engagement. By filtering qualified participants early and building trust through personal interactions, these strategies streamline the first site visit and enhance overall recruitment success.

Rare disease patients often endure a prolonged journey to get an accurate diagnosis, facing multiple specialists, conflicting opinions, and significant personal challenges. Comprehensive resources and patient stories can provide valuable information and emotional support, helping patients and caregivers make informed decisions and foster a sense of community.

Clinical research drives medical advancements but faces significant challenges in recruiting participants, particularly from minority groups. At PatientWing, we are dedicated to overcoming these barriers and achieving true diversity in clinical trials through collaborative efforts from providers, sponsors, and participants.

Five patients that PatientWing enrolled showed significant improvements in/after the study with attention test after deep brain stimulation.

PatientWing is excited to attend the 20th BioPharma Clinical Trials Nexus Conference in San Diego, California May 8th – 9th.

PatientWing is thrilled to participate in the Diversity Alliance for Science (DA4S) East Coast Conference in Newark, New Jersey from April 30th to May 2nd

PatientWing is making waves at SCOPE Summit 2024! As a sponsor and finalist for the Participant Engagement Award, we're set to take center stage at Booth 1113. Dive into groundbreaking advancements in participant recruitment and enrollment, explore our award-worthy journey, and connect with us at this exciting event!

The FDA issued a draft guidance in 2022, urging industry sponsors to develop a Race and Ethnicity Diversity Plan for clinical trial participation, focusing on underrepresented groups. The guidance, while not legally binding, reflects an industry shift towards diverse patient recruitment, with specific requirements for data collection and enrollment strategies for diverse participants.

Compliance with evolving consumer and patient privacy regulations has increased the burden on biopharmaceutical companies running clinical trials. Learn how to meet these requirements through technological, procedural, legal, data storage, and data transfer considerations.